This Week's Confirmed Earnings

Loading…

The Earnings Whisper® Number

Read more →

The market's true earnings expectation — and why beating the consensus estimate isn't enough.

Meme: beating the consensus estimate is not the same as beating expectations.

Analysts update their models constantly, but they rarely publish every revision. The Earnings Whisper® number captures what they actually expect — and across two decades and more than 144,000 published numbers, it has landed closer to actual reported earnings than the published consensus 69.7% of the time. Consequently, there is no statistical benefit to beating the consensus estimate.

Beat the Whisper and the estimate +1.9% Beat the Estimate but missed the Whisper −0.7%
Average day-of move, since February 1999.

Companies that beat the Whisper closed higher by an average of 1.9%. Those that cleared the published estimate but fell short of the Whisper closed lower 54.9% of the time. There is no statistical benefit to beating the consensus estimate — only the Whisper.

The Whisper Report®

See all

The Right Side

Monday, July 27, 2026
There is more than one way to measure sentiment, and they aren't all giving the same signal.
Read Report

Top Earnings News

See all

The recent, most closely watched, earnings results.

FIBROBIOLOGICS Beat Consensus Estimates

Friday, July 31, 2026 at 5:34 PM
FIBROBIOLOGICS (FBLG) reported a loss of $0.66 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.93 per share. The company beat consensus estimates by 29.03%.

FibroBiologics Inc. is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics Inc. is based in HOUSTON.

Arbor Realty Trust Beat Consensus Estimates

Friday, July 31, 2026 at 8:30 AM
Arbor Realty Trust (ABR) reported earnings of $0.08 per share on revenue of $230.86 million for the second quarter ended June 2026. The consensus earnings estimate was $0.05 per share on revenue of $230.69 million. The company beat consensus estimates by 60.00% while revenue fell 3.93% compared to the same quarter a year ago.

Arbor Realty Trust Inc is a real estate finance company. The Company invests in a diversified portfolio of structured finance assets in the multi-family and commercial real estate markets. It also invest in real estate-related bridge and mezzanine loans.

iRadimed Missed Consensus Estimates, Reaffirms Above Estimates

Friday, July 31, 2026 at 8:15 AM
iRadimed (IRMD) reported earnings of $0.41 per share on revenue of $20.47 million for the second quarter ended June 2026. The consensus earnings estimate was $0.42 per share. The company missed consensus estimates by 2.38% while revenue grew 0.28% on a year-over-year basis.

The company said it expects third-quarter non-GAAP earnings of $0.54 to $0.59 per share on revenue of $23.0 million to $24.50 million. The current consensus earnings estimate is $0.54 per share on revenue of $23.7 million for the quarter ending September 30, 2026. The company also said it continues to expect 2026 non-GAAP earnings of $2.09 to $2.24 per share on revenue of $91.0 million to $96.0 million. The current consensus earnings estimate is $2.08 per share on revenue of $91.2 million for the year ending December 31, 2026.

iRadimed Corp develops, manufacture, market and distribute Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally.

The Drift

Read more
Upcoming Earnings

The Most Anticipated Earnings Releases for the Week of August 3, 2026

August 1, 2026
PLTR SNDK AMD SPCX LLY APP
This week the earnings machine roars back to life, and if the mood music is any guide, technology is once again the star of the show. Palantir headlines a crowded stage where the crowd is leaning decidedly optimistic, and it is joined by a chorus of chip and hardware names like SanDisk, Advanced Micro Devices, Arista Networks and Western Digital, all of which are walking in with the wind at their backs after strong finishes to last quarter. Options traders are bracing for fireworks in some of these names, with several capable of swinging ten percent or more in a single session, so buckle up. Not everyone gets a warm welcome, though. Eli Lilly and Novo Nordisk, the twin titans of the weight loss craze, are drawing a surprisingly frosty reception despite their blockbuster reputations, and Pfizer continues to fight an uphill battle for investor affection. Even SpaceX makes a rare appearance on the earnings calendar, a reminder that the rocket business now commands as much attention as the boardroom.
Continue reading →

Recent Positive Earnings

XMTR 12.8% since the report 9.2% above its post-earnings high